The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat

Psychopharmacology

Volumn 210, Issue 2, 2010, Pages 231-240

  Tejeda, Hugo A ^a,b   Chefer, Vladimir I ^a   Zapata, Agustin ^a   Shippenberg, Toni S ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Corticotropin releasing factor; Kappa opioid receptors; Prepulse inhibition; Rat

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; CORTICOTROPIN RELEASING FACTOR; DIZOCILPINE; DYNORPHIN; KAPPA OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE; QUINPIROLE; SALVINORIN A;

ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; EVOKED RESPONSE; MALE; NEUROMODULATION; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SENSORY GATING; STARTLE REFLEX; STRESS; ANIMAL BEHAVIOR; ANIMAL MODEL; BEHAVIOR CONTROL; BEHAVIOR DISORDER; NEUROPATHOLOGY; PSYCHOPHARMACOLOGY;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; BENZENEACETAMIDES; CORTICOTROPIN-RELEASING HORMONE; DITERPENES, CLERODANE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIGANDS; MALE; NALTREXONE; NEURAL INHIBITION; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; STARTLE REACTION;

EID: 77953293690     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1799-6     Document Type: Article

References (81)

1. Armario A, Escorihuela RM, Nadal R (2008) Long-term neuroendocrine and behavioural, effects of a single exposure to stress in adult animals. Neurosci Biobehav Rev 32:1121-1135
2. Arnsten AF (2007) Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness. Cereb Cortex 17:6-15
3. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidtae-taduced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794
4. Bortolato M, Solbrig MV (2007) The price of seizure control: dynorphtas in interictal and postictal psychosis. Psychiatry Res 151:139-143 (Pubitemid 46634638)
5. Bortolato M, Am GN, Frau R, Orrù M, Fà M, Manunta M, Puddu M, Mereu G, Gessa GL (2005) Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats. Biol Psychiatry 57:1550-1558 (Pubitemid 40805385)
6. Bruchas MR, Land BB, Chavkin C (2009) The dynorphin/kappa opioid system as a modulator of stress-induced, and pro-addictive behaviors. Brain Res. doi:10.1016/j.brainres.2009.08.062
7. Bubser M, Koch M (1994) Prepulse inhibition of the acoustic startle response of rats is reduced, by 6-hydroxydopamtae lesions of the medial prefrontal cortex. Psychophannacology (Berl) 113:487-492 (Pubitemid 24150499)
8. Byrnes JJ, Hammer RP (2000) The disruptive effect of cocaine on prepulse inhibition is prevented by repeated administration in rats. Neuropsychopharmacology 22:551-554
9. Cahill CM, Green MJ, Jairani R, Malhi GS (2007) Do cognitive deficits in juvenile bipolar disorder persist into adulthood? J Nerv Ment Dis 195:891-896
10. Carey AN, Lyons AM, Shay CF, Dunton O, McLaughlin JP (2009) Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory. J Neurosci 29:4293-4300
11. Carlezon WA Jr, Béguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM (2006) Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochcmistry in rats. J Pharmacol Exp Ther 316(1):440-447
12. Carlezon WA Jr, Béguin C, Knoll AT, Cohen BM (2009) Kappaopioid ligands in the study and treatment of mood disorders. Pharmacol Ther 123:334-343
13. Chefer VI, Shippenberg TS (2006) Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens. Eur J NeuroSci 23:229-238
14. Chefer VI, Czyzyk. T, Bolan EA, Moron J, Pintar JE, Shippenberg TS (2005) Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. Neurosci 18:5029-5037
15. Conti LH, Murry JD, Ruiz MA, Printz MP (2002) Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains. Psychopharmacology (Berl) 161:296-303
16. Conti LH, Costill JE, Flynn S, Tayler JE (2005) Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain. Behav Neurosci 119:1052-1060
17. Daumas S, Betourne A, Halley H, Wolfer DP, Lipp HP, Lassalle JM, Francés B (2007) Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice. Neurobiol Learn Mem 88:94-103
18. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278
19. Dirks A, Groenink L, Westphal KG, Olivier JD, Verdouw PM, van der Gugten J, Geyer MA, Olivier B (2003) Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs. Neuropsychopharmacology 28:1790-1798
20. Doherty JM, Masten VL, Powell SB, Ralph RJ, Klamer D, Low MJ, Geyer MA (2008) Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice. Neuropsychopharmacology 33:2648-2656
21. El-Rawas R, Saadé NE, Thiriet N, Atweh S, Jaber M, Al-Amin HA (2009) Developmental changes in the mRNA expression of neuropeptides and dopamine and glutamate receptors in neonates and adult rats after ventral hippocampal lesion. Schizophr Res 113:298-307
22. Endoh T, Matsuura H, Tanaka C, Nagase H (1992) Norbinaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 316:30-42
23. Ermutlu MN, Karamürsel S, Ugur EH, Senturk L, Goklian N (2005) Effects of cold stress on early and late stimulus gating. Psychiatry Res 136:201-209
24. Faraday MM (2002) Rat sex and strata differences in responses to stress. Physiol Behav 75:507-522
25. Geyer MA (2006) The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps? Dialogues Clin Neurosci 8:9-16
26. Geyer MA (2008) Developing translational animal models for symptoms of schizophrenia or bipolar mania Neurotox Res 14:71-78
27. Goel N, Bale TL (2009) Examining the intersection of sex and stress in modelling neuropsychiatrie disorders. J Ncuroendocrinol 21:415-420
28. Grillon C, Morgan CA, Southwick SM, Davis M, Chamey DS (1996) Baseline startle amplitude and prepulse inhibition in Vietnam veterans with, posttraumatic stress disorder. Psychiatry Res 64:169-178
29. Groentak L, Dirks A, Verdouw PM, de Graaff M, Peelers BW, Millan MJ, Olivier B (2008) CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpresstag CRF. Biol Psychiatry 63:360-368
30. Heidbreder CA, Schenk S, Partridge B, Shippenberg TS (1998) Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist. Synapse 30:255-262 (Pubitemid 28447173)
31. Heikkilä L, Rimón R, Terenius L (1990) Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients. Psychiatry Res 34:229-236
32. Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull 35:549-562
33. Hurd YL (1996) Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience 72:767-783 (Pubitemid 26124696)
34. Hurd YL (2002) Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex. Mol Psychiatry 7:75-81
35. Keefe RS, Fenton WS (2007) How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr Bull 33:912-920
36. Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA Jr (2007) Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 323:838-845
37. Koch M, Bubser M (1994) Deficient sensorimotor gating after 6-hydroxydopamtae lesion of the rat medial prefrontal cortex is reversed by haloperidol. Eur J NeuroSci 6:1837-1845
38. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28:407-414
39. Leitner DS (1986) Alterations in other sensory modalities accompanying stress analgesia as measured by startle reflex modification. Ann N Y Acad Sci 467:82-92
40. Leitner DS (1989) Multisensory deficits in rats produced by acute exposure to cold swim stress. Behav Neurosci 103:151-157
41. Levin ED, Petro A, Caldwell DP (2005) Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-Daspartate (NMDA) glutamatergic receptor blockade. Prog Neuropsychopharmacol Biol Psychiatry 29:581-586 (Pubitemid 40603834)
42. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphtae. Psychopharmacology (Berl) 122:35-43
43. Lipska BK, Lerman DN, Khaing ZZ, Weickert CS, Weinberger DR (2003) Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur J NeuroSci 18:391-402
44. Ludewig K, Geyer MA, Vollenweider FX (2003) Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biol Psychiatry 54:121-128
45. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) 94:507-514
46. Mansour A, Burke S, Pavlic RJ, Akil H, Watson SJ (1996) Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience 71:671-690
47. Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL (2006) Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal, cortex. Proc Natl Acad Sci USA 103:2938-2942
48. McDaniel KL, Mundy WR, Tilson HA (1990) Microinjection of dynorphin into the hippocampus impairs spatial learning in rats. Pharmacol Biochem Behav 35:429-435
49. McLaughlin JP, Land BB, Li S, Pintar JE, Chavkin C (2006) Prior activation of kappa opioid receptors by U50, 488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology 31:787-794
50. Millan MJ, Schreiber R, Dekeyne A, Rivet JM, Bervoets K, Mavridis M, Sebban C, Maurel-Remy S, Newman-Tancredi A, Spedding M, Muller O, Lavielle G, Brocco M (1998) S 16924 ((R)-2-[1-[2-(2, 3-dihydro-benzo[1, 4] dioxta-5-yloxy)-ethyl]-pyrrolidin-3yl]1-(4-fluoro-phenyl)-ethanone), a novel, potential, antipsychotic with marked, serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol. J Pharmacol Exp Ther 286:1356-1373
51. Miyazato H, Skinner RD, Garcia-Rill E (2000) Locus coeruleus involvement in the effects of immobilization stress on the p13 midlatency auditory evoked potential in the rat. Prog Neuropsychopharmacol Biol Psychiatry 24:1177-1201
52. Nespor AA, Tizabi Y (2008) Effects of nicotine on quinpirole- and dizocilptae (MK-801)-induced sensorimotor gating impairments in rats. Psychopharmacology (Berl) 200:403-411
53. Omitz EM, Pynoos RS (1989) Startle modulation in children with posttraumatic stress disorder. Am J Psychiatry 146:866-870 (Pubitemid 19180964)
54. Paulzen M, Gründer G (2008) Toxic psychosis after intake of the hallucinogen salvinorin A. J Clin Psychiatry 69:1501-1502
55. Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774-776
56. Plappert CF, Pilz PK (2002) Difference in anxiety and sensitization of the acoustic startle response between the two inbred mouse strains BALB/cAN and DBA/2 N. Genes Brain Behav 1:178-186
57. Pulliam JV, Dawaghreh AM, Alema-Mensah E, Plotsky PM (2009) Social defeat stress produces prolonged alterations in acoustic startle and body weight gain in male Long Evans rats. J Psychiatr Res. doi: 10.1016/j.jpsychires.2009.05.005
58. Ralph RJ, Paulus MP, Fumagalli F, Caron MG, Geyer MA (2001) Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J Neurosci 21:305-313
59. Ralph-Williams RJ, Paulus MP, Zhuang X, Hen R, Geyer MA (2003) Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biol Psychiatry 53:352-359
60. Redila VA, Chavkin C (2008) Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl) 200:59-70
61. Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA (2004) Corticotropin-releasing factor receptors CRFl and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci 24:6545-6552
62. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 99:11934-11939
63. Sandin J, Nylander I, Georgieva J, Schott PA, Ogren SO, Terenius L (1998) Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect. Neuroscience 85:375-382
64. Shippenberg TS, Zapata. A, Chefer VI (2007) Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 116:306-321
65. Shoemaker JM, Saint Marie RL, Bongiovanni MJ, Neary AC, Tochen LS, Swerdlow NR (2005) Prefrontal Dl and ventral hippocampal N-methyl-D-aspartate regulation of startle gating in rats. Neuroscience 135:385-394
66. Sipos ML, Bauman RA, Widholm JJ, Kant GJ (2000) Behavioral effects Of 8-OH-DPAT in chronically stressed, male and female rats. Pharmacol Biochem Behav 66:403-411 (Pubitemid 30394630)
67. Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050
68. Sutherland JE, Page ME, Conti LH (2008) The effect, of corticotropinreleasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats. Pharmacol Biochem Behav 89:324-337
69. Svingos AL, Colago EE (2002) Kappa-opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex. Brain Res 946:262-271
70. Swerdlow NR, Braff DL, Masten VL, Geyer MA (1990) Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl) 101:414-420
71. Swerdlow NR, Keith. VA, Braff DL, Geyer MA (1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphtae inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530-536
72. Swerdlow NR, Braff DL, Geyer MA (1999) Cross-species studies of sensorimotor gating of the startle reflex. Ann N Y Acad. Sci 877:202-216 (Pubitemid 29351859)
73. Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA (2000) Toward understanding the biology of a complex phenotype: rat strata and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci 20:4325-4336 (Pubitemid 30365703)
74. Swerdlow NR, Shoemaker JM, Bongiovanni MJ, Neary AC, Tochen LS, Saint Marie RL (2007) Strain differences in the disruption of prepulse inhibition of startle after systemic and tatra-accumbens amphetamine administration. Pharmacol Biochem Behav 87:1-10
75. Tejeda HA (2009) Modulation of extracellular dopamine in the prefrontal cortex by local and ventral tegmental area kappa-opioid receptors. 40th Ann. Soc for Neurosci Meeting, Chicago, IL, 56:7517
76. Thompson AC, Zapata A, Justice JB Jr, Vaughan RA, Sharpe LG, Shippenberg TS (2000) Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. J Neurosci 20:9333-9340
77. Vinkers CH, Risbrough VB, Geyer MA, Caldwell S, Low MJ, Hauger RL (2007) Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating. Pharmacol Biochem Behav 86:550-558
78. Wan. FJ, Swerdlow NR (1993) Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology (Berl) 113:103-109
79. Weber M, Chang WL, Breier M, Ko D, Swerdlow NR (2008) Heritable strain differences in sensitivity to the startle gatingdisruptive effects of D2 but not D3 receptor stimulation. Behav Pharmacol 19:786-795
80. Wevers A, Schmidt P, Cserpan E, Cserpan I, Maderspach K, Staak M, Schröder H (1995) Cellular distribution of the mRNA for the kappa-opioid receptor in the human neocortex: a non-isotopic in situ hybridization study. Neurosci Lett 195:125-128
81. Yamashita M, Fukushima S, Shen HW, Hall FS, Uhl GR, Numachi Y, Kobayashi H, Sora I (2006) Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacology 31:2132-2139 (Pubitemid 44413190)